NO933341L - Fordindelser mot kreft - Google Patents
Fordindelser mot kreftInfo
- Publication number
- NO933341L NO933341L NO933341A NO933341A NO933341L NO 933341 L NO933341 L NO 933341L NO 933341 A NO933341 A NO 933341A NO 933341 A NO933341 A NO 933341A NO 933341 L NO933341 L NO 933341L
- Authority
- NO
- Norway
- Prior art keywords
- carbon atoms
- alkyl
- alkoxy
- hydroxy
- halogen
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 12
- 125000000217 alkyl group Chemical group 0.000 abstract 9
- 125000003545 alkoxy group Chemical group 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000002367 halogens Chemical class 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- -1 hydroxy- Chemical class 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- 125000005236 alkanoylamino group Chemical group 0.000 abstract 2
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 2
- 150000008574 D-amino acids Chemical group 0.000 abstract 1
- 108010016626 Dipeptides Proteins 0.000 abstract 1
- 125000000729 N-terminal amino-acid group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000000278 alkyl amino alkyl group Chemical group 0.000 abstract 1
- 125000006350 alkyl thio alkyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000005242 carbamoyl alkyl group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000004181 carboxyalkyl group Chemical group 0.000 abstract 1
- 125000003790 chinazolinyl group Chemical group 0.000 abstract 1
- 125000004966 cyanoalkyl group Chemical group 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000005358 mercaptoalkyl group Chemical group 0.000 abstract 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 125000003396 thiol group Chemical class [H]S* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919105771A GB9105771D0 (en) | 1991-03-19 | 1991-03-19 | Anti-cancer compounds |
| PCT/GB1992/000476 WO1992016512A1 (en) | 1991-03-19 | 1992-03-18 | Anti-cancer compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO933341D0 NO933341D0 (no) | 1993-09-20 |
| NO933341L true NO933341L (no) | 1993-11-18 |
Family
ID=10691801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO933341A NO933341L (no) | 1991-03-19 | 1993-09-20 | Fordindelser mot kreft |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5444061A (https=) |
| EP (1) | EP0509643A1 (https=) |
| JP (1) | JPH06505974A (https=) |
| AU (1) | AU655970B2 (https=) |
| CA (1) | CA2106583A1 (https=) |
| CZ (1) | CZ195393A3 (https=) |
| FI (1) | FI934106A7 (https=) |
| GB (2) | GB9105771D0 (https=) |
| HU (1) | HUT67177A (https=) |
| IE (1) | IE920853A1 (https=) |
| IL (1) | IL101281A0 (https=) |
| MX (1) | MX9201183A (https=) |
| NO (1) | NO933341L (https=) |
| NZ (1) | NZ242023A (https=) |
| SK (1) | SK100993A3 (https=) |
| TW (1) | TW203608B (https=) |
| WO (1) | WO1992016512A1 (https=) |
| ZA (1) | ZA921985B (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9205907D0 (en) * | 1992-03-18 | 1992-04-29 | Cancer Res Inst Royal | Anti-cancer compounds |
| GB9223352D0 (en) * | 1992-11-06 | 1992-12-23 | Ici Plc | Tricyclic compounds |
| GB9408936D0 (en) * | 1994-05-05 | 1994-06-22 | Cancer Res Inst | Anti-cancer compounds |
| BR9610422A (pt) * | 1995-08-30 | 1999-07-13 | Searle & Co | Derivados de meta-guanidina uréia tiouréia ou ácido aminobenzóico azacíclico como antagonistas de integrina |
| GB9904275D0 (en) | 1999-02-24 | 1999-04-21 | Cancer Res Campaign Tech | Anti-cancer compounds |
| US6545004B1 (en) * | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
| US7671200B2 (en) * | 1999-10-27 | 2010-03-02 | Cytokinetics, Inc. | Quinazolinone KSP inhibitors |
| US7230000B1 (en) | 1999-10-27 | 2007-06-12 | Cytokinetics, Incorporated | Methods and compositions utilizing quinazolinones |
| WO2003070701A2 (en) * | 2002-02-15 | 2003-08-28 | Cytokinetics, Inc. | Syntheses of quinazolinones |
| US7214800B2 (en) * | 2002-05-09 | 2007-05-08 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| CA2485148A1 (en) * | 2002-05-09 | 2003-11-20 | Cytokinetics, Inc. | Pyrimidinone compounds, compositions and methods |
| EP1513820A4 (en) * | 2002-05-23 | 2006-09-13 | Cytokinetics Inc | COMPOUNDS, COMPOSITIONS AND METHODS |
| WO2003106426A1 (en) * | 2002-06-14 | 2003-12-24 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| US20030236430A1 (en) * | 2002-06-21 | 2003-12-25 | Allen David Robert | Preparation of protected amino acids |
| AU2003256805A1 (en) * | 2002-07-23 | 2004-02-09 | Cytokinetics, Inc. | Compounds compositions and methods |
| US20040048853A1 (en) * | 2002-08-21 | 2004-03-11 | Gustave Bergnes | Compounds, compositions, and methods |
| WO2004034972A2 (en) | 2002-09-30 | 2004-04-29 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| JP2007510652A (ja) * | 2003-11-03 | 2007-04-26 | サイトキネティクス・インコーポレーテッド | ピリミジン−４−オン化合物、組成物、および方法 |
| EP1680420A4 (en) * | 2003-11-07 | 2008-09-24 | Cytokinetics Inc | COMPOUNDS, COMPOSITIONS AND METHODS |
| EP1692112A4 (en) * | 2003-12-08 | 2008-09-24 | Cytokinetics Inc | COMPOUNDS, COMPOSITIONS, AND METHODS |
| DK2150514T3 (en) | 2007-04-11 | 2019-02-18 | Merck & Cie | 18F-LABELED FOLATES |
| KR102431436B1 (ko) | 2014-08-29 | 2022-08-10 | 테스 파마 에스.알.엘. | α-아미노-β-카복시뮤콘산 세미알데히드 데카복실라제의 억제제 |
| US12030875B2 (en) | 2018-09-07 | 2024-07-09 | PIC Therapeutics, Inc. | EIF4E inhibitors and uses thereof |
| AU2021230289A1 (en) | 2020-03-03 | 2022-09-29 | PIC Therapeutics, Inc. | eIF4E inhibitors and uses thereof |
| JP2024534127A (ja) | 2021-08-25 | 2024-09-18 | ピク セラピューティクス， インコーポレイテッド | ｅＩＦ４Ｅ阻害剤及びその使用 |
| US12157732B2 (en) | 2021-08-25 | 2024-12-03 | PIC Therapeutics, Inc. | eIF4E inhibitors and uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3069468D1 (en) * | 1979-12-19 | 1984-11-22 | Nat Res Dev | Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents |
| GB8513754D0 (en) * | 1985-05-31 | 1985-07-03 | Jones T R | Anti-cancer quinazoline derivatives |
| US4746659A (en) * | 1985-12-30 | 1988-05-24 | Sri International | Diastereomers of 10-alkyl-10-deazaminopterins and process for preparing the same |
| GB8607683D0 (en) * | 1986-03-27 | 1986-04-30 | Ici Plc | Anti-tumor agents |
| US5187167A (en) * | 1986-03-27 | 1993-02-16 | Imperial Chemical Industries Plc | Pharmaceutical compositions comprising quinazolin-4-one derivatives |
| GB8625019D0 (en) * | 1986-10-18 | 1986-11-19 | Wellcome Found | Compounds |
| GB8707053D0 (en) * | 1987-03-25 | 1987-04-29 | Ici Plc | Anti-tumour agents |
| US4767761A (en) * | 1987-11-04 | 1988-08-30 | Dana-Farber Cancer Institute, Inc. | Ornithine derivatives and their use as methotrexate-resistant cell inhibitors |
| GB8727737D0 (en) * | 1987-11-26 | 1987-12-31 | Ici Plc | Antitumour agents |
| GB8809978D0 (en) * | 1988-04-27 | 1988-06-02 | Ici Plc | Anti-tumour agents |
| US5252573A (en) * | 1988-12-15 | 1993-10-12 | Imperial Chemical Industries Plc | Anti-tumor agents |
| GB8829296D0 (en) * | 1988-12-15 | 1989-01-25 | Ici Plc | Anti-tumour compounds |
| US4996207A (en) * | 1990-01-18 | 1991-02-26 | Nair Madhavan G | Three new non-polyglutamatable deazaaminopterins |
| DE69111891T2 (de) * | 1990-05-17 | 1996-04-04 | Smith & Nephew United Inc | Elektrisch leitender und adstringierender Film sowie filmbildende Zusammensetzung zur Verwendung auf der Haut. |
| IL98167A0 (en) * | 1990-05-30 | 1992-06-21 | Ici Plc | Anti-tumour quinazoline derivatives,processes for their preparation and pharmaceutical compositions comprising them |
-
1991
- 1991-03-19 GB GB919105771A patent/GB9105771D0/en active Pending
-
1992
- 1992-03-18 IL IL101281A patent/IL101281A0/xx unknown
- 1992-03-18 HU HU9302636A patent/HUT67177A/hu unknown
- 1992-03-18 AU AU13716/92A patent/AU655970B2/en not_active Expired - Fee Related
- 1992-03-18 GB GB9205906A patent/GB2253849B/en not_active Expired - Fee Related
- 1992-03-18 EP EP92302304A patent/EP0509643A1/en not_active Withdrawn
- 1992-03-18 IE IE085392A patent/IE920853A1/en unknown
- 1992-03-18 WO PCT/GB1992/000476 patent/WO1992016512A1/en not_active Ceased
- 1992-03-18 US US08/122,473 patent/US5444061A/en not_active Expired - Fee Related
- 1992-03-18 ZA ZA921985A patent/ZA921985B/xx unknown
- 1992-03-18 CA CA002106583A patent/CA2106583A1/en not_active Abandoned
- 1992-03-18 MX MX9201183A patent/MX9201183A/es unknown
- 1992-03-18 JP JP4506050A patent/JPH06505974A/ja active Pending
- 1992-03-18 SK SK1009-93A patent/SK100993A3/sk unknown
- 1992-03-19 CZ CS931953A patent/CZ195393A3/cs unknown
- 1992-04-27 TW TW081103276A patent/TW203608B/zh active
- 1992-05-18 NZ NZ242023A patent/NZ242023A/en unknown
-
1993
- 1993-09-20 FI FI934106A patent/FI934106A7/fi not_active Application Discontinuation
- 1993-09-20 NO NO933341A patent/NO933341L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ242023A (en) | 1993-12-23 |
| TW203608B (https=) | 1993-04-11 |
| HUT67177A (en) | 1995-02-28 |
| JPH06505974A (ja) | 1994-07-07 |
| HU9302636D0 (en) | 1993-12-28 |
| NO933341D0 (no) | 1993-09-20 |
| CA2106583A1 (en) | 1992-09-20 |
| FI934106A7 (fi) | 1993-11-18 |
| GB2253849B (en) | 1995-01-18 |
| GB9205906D0 (en) | 1992-04-29 |
| GB9105771D0 (en) | 1991-05-01 |
| US5444061A (en) | 1995-08-22 |
| AU655970B2 (en) | 1995-01-19 |
| FI934106A0 (fi) | 1993-09-20 |
| MX9201183A (es) | 1994-06-30 |
| ZA921985B (en) | 1993-09-20 |
| SK100993A3 (en) | 1994-08-10 |
| WO1992016512A1 (en) | 1992-10-01 |
| CZ195393A3 (en) | 1994-07-13 |
| IL101281A0 (en) | 1992-11-15 |
| IE920853A1 (en) | 1992-09-23 |
| EP0509643A1 (en) | 1992-10-21 |
| AU1371692A (en) | 1992-10-21 |
| GB2253849A (en) | 1992-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO933341L (no) | Fordindelser mot kreft | |
| CA2140598A1 (en) | Prolineamide derivatives | |
| US4692458A (en) | Anti-hypertensive agents | |
| CA2078790A1 (en) | 3-benzylidene-1-carbamoyl-2-pyrrolidone analogues | |
| KR870007205A (ko) | 펩티딜아미노디올 | |
| KR890013035A (ko) | 인돌로카르바졸 유도체와 그 제조방법 및 그들을 함유하는 약제조성물 | |
| DE69427800D1 (de) | Methode zur Hemmung der Endometriose | |
| HUP9903336A2 (hu) | Szulfonsav-N-[(amino-imino-metil)-fenil]-aza-heretero-ciklil-amid származékok és az ezeket tartalmazó gyógyszerkészítmények | |
| CA2117543A1 (en) | Dipeptidylquinazolones as anti-cancer agents | |
| KR870007204A (ko) | 작용화 펩티딜 아미노디올 및-트리올 | |
| KR950703554A (ko) | 피페라진 유도체 및 그의 염(piperazine derivatives and salts thereof) | |
| TW249804B (https=) | ||
| FR2679555B1 (fr) | Nouveaux derives de l'uree, leur preparation et leur application en therapeutique. | |
| OA08715A (fr) | Nouveaux dérivés peptidiques à structure polyclique azotée, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
| KR870007164A (ko) | 모노술팍탐 | |
| KR930007914A (ko) | 제1위치에 에테르 또는 티오에테르 그룹을 함유하는 프탈라진 및 이의 제조방법 | |
| KR930012698A (ko) | β-옥소-β-벤젠프로판티오아미드 유도체 | |
| DK384485A (da) | 1,6-naphthyridinderivater med kardilaterende virkning | |
| HRP920948A2 (en) | Nitratoalkanecarbone acid derivatives, process for the preparation thereof, the use of the same and drugs containing them | |
| KR830008998A (ko) | N-치환된-아미노-아미노산의 제조방법 | |
| KR950702544A (ko) | 비페닐메탄 유도체 및 이를 함유하는 약제 | |
| EA199800464A1 (ru) | Синергическая иммуносупрессорная композиция, содержащая 2,2'-би-1н-пиррольное соединение | |
| EA199800085A1 (ru) | Способ лечения боли висцерального происхождения, способ лечения воспалительного колита | |
| KR950016720A (ko) | 아밀로이드 단백질의 효과를 저해하는 방법 | |
| US4690936A (en) | Anti-hypertensive agents |